Threshold Crossing: The Goldman Sachs Group Reduces its Stake in ABIVAX

The Goldman Sachs Group, Inc. recently announced that it has crossed below the 5% ownership threshold in ABIVAX. Through its controlled entities, Goldman Sachs now holds 4.86% of the share capital, representing 4,237,129 shares and 4.79% of the voting rights. This change resulted from an off-market sale of shares.

Specifically, Goldman Sachs & Co. LLC is the largest shareholder with 3,236,835 shares. Other entities, such as Goldman Sachs International and Goldman Sachs Asset Management LP, also hold shares.

Goldman Sachs maintains an indirect position in 2,720,941 shares through securities lending and option contracts. In addition, 1,351,731 shares are linked to swap contracts exercisable until 2036.